Murphy Sean

CIK 00016850424 companiesWESTMINSTER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001685042

Recent Transactions

32 trades

Award
TriSalus Life Sciences, Inc.$TLSI
Director Stock Option (right to buy)
2025-06-12+15,000→ 554,681 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-05-19$5.18/sh+44,884→ 123,989 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-02-18+15,817→ 79,105 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-28$5.17/sh+15,000→ 197,732 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-27$5.31/sh+15,000→ 182,732 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2025-01-27+75,000→ 75,000 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-27+12,500→ 63,288 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2024-02-12+105,000→ 105,000 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-02-12+34,144→ 50,788 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2024-01-24+125,000→ 125,000 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2023-08-11+62,500→ 62,500 total
Disposition to Issuer
Radius Health, Inc.
Stock Option (Right to Buy)
2022-08-15$3.60/sh−10,000→ 0 total
Disposition from Tender
Radius Health, Inc.
Common Stock
2022-08-15$10.00/sh−5,500→ 0 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2022-01-14+10,000→ 10,000 total
Award
Radius Health, Inc.
Common Stock
2022-01-14+5,500→ 11,000 total
Award
Radius Health, Inc.
Common Stock
2021-02-22+5,500→ 5,500 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2021-02-22+10,000→ 10,000 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2021-01-21+20,000→ 20,000 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2020-08-10+30,000→ 30,000 total
Conversion
Poseida Therapeutics, Inc.
Series A Preferred Stock
2020-07-14−8,746,356→ 0 total
Conversion
Poseida Therapeutics, Inc.
Series C Preferred Stock
2020-07-14−392,927→ 0 total
Conversion
Poseida Therapeutics, Inc.
Common Stock
2020-07-14+690,124→ 8,873,027 total
Conversion
Poseida Therapeutics, Inc.
Common Stock
2020-07-14+1,168,985→ 8,182,903 total
Conversion
Poseida Therapeutics, Inc.
Common Stock
2020-07-14+7,013,918→ 7,013,918 total
Conversion
Poseida Therapeutics, Inc.
Common Stock
2020-07-14+315,098→ 9,188,125 total
Purchase
Poseida Therapeutics, Inc.
Common Stock
2020-07-14$16.00/sh+10,000→ 10,000 total
Conversion
Poseida Therapeutics, Inc.
Series A-1 Preferred Stock
2020-07-14−1,457,725→ 0 total
Conversion
Poseida Therapeutics, Inc.
Series B Preferred Stock
2020-07-14−860,585→ 0 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2020-07-09+20,000→ 20,000 total
Award
NVN Liquidation, Inc.
Stock Option (Right to Buy)
2018-06-04+20,000→ 20,000 total
Award
NVN Liquidation, Inc.
Stock Option (right to buy)
2017-06-05+34,014→ 34,014 total
Award
NVN Liquidation, Inc.
Stock Option
2016-09-20+14,484→ 14,484 total

Companies

Recent Filings

Address

6272 W. 91ST AVENUE

WESTMINSTER, CO, 80031

View on SEC.gov